1、Enough Cases Clinical Trials

RESULTS
Found (1) clinical trials

Recombine Endostatin in Alliance With Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation in Locoregionally Advanced Nasopharyngeal Carcinoma

Phase 2/Phase 3